Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer

ABSTRACT: Objective: This article reports a case of secondary hypothyroidism occurring during the withdrawal of thyroid hormone replacement in a patient with thyroid cancer that led to the discovery of simultaneous panhypopituitarism and hyperprolactinemia that were caused by an internal carotid art...

Full description

Bibliographic Details
Main Authors: Michael H. Goldman, MD, Alison T. Gruber, Marc A. Herman, MD
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520303023
id doaj-97c11492c7bf4430998b61ad3e496fdc
record_format Article
spelling doaj-97c11492c7bf4430998b61ad3e496fdc2021-04-30T07:24:18ZengElsevierAACE Clinical Case Reports2376-06052016-01-0122e167e171Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid CancerMichael H. Goldman, MD0Alison T. Gruber1Marc A. Herman, MD2Englewood Hospital; Englewood Cliffs, New Jersey.; Address correspondence to Dr. Michael H. Goldman, Englewood Hospital, 600 E Palisade Avenue # 1, Englewood Cliffs, New Jersey 07632.Englewood Hospital; Englewood Cliffs, New Jersey.Englewood Hospital; Englewood Cliffs, New Jersey.ABSTRACT: Objective: This article reports a case of secondary hypothyroidism occurring during the withdrawal of thyroid hormone replacement in a patient with thyroid cancer that led to the discovery of simultaneous panhypopituitarism and hyperprolactinemia that were caused by an internal carotid artery aneurysm. The discovery of the secondary hypothyroidism necessitated further pituitary hormone analysis and medical imaging to identify the precise pathologic etiology.Methods: The methods used included the evaluation of selected thyroid and pituitary hormone concentrations and subsequent pituitary magnetic resonance imaging.Results: An 86-year-old African-American female with a history of thyroid cancer exhibited a suppressed serum thyroid-stimulating hormone concentration that failed to increase during progressive lowering of her thyroxine dosage despite it causing a simultaneous subnormal free thyroxine concentration. Laboratory findings indicated secondary hypothyroidism and subsequently panhypopituitarism and hyperprolactinemia. Pituitary magnetic resonance imaging revealed the presence of a large carotid aneurysm that had invaded the sella turcica. Additional hormone analyses revealed elevated prolactin, low gonadotropins, low baseline cortisol within an inappropriately normal adrenocorticotropic hormone concentration, and a low cortisol concentration following cortrosyn stimulation.Conclusion: Panhypopituitarism and hyperprolactinemia were revealed in a patient with thyroid cancer during thyroid hormone withdrawal, leading to the discovery of a giant internal carotid artery aneurysm invading the pituitary fossa. Physicians should be alert to the possibility of secondary hypopituitarism when an expected rise in thyroid-stimulating hormone while tapering thyroid hormone replacement in a low risk thyroid cancer patient fails to occur.Abbreviations: FT4 = free thyroxine TSH = thyroid stimulating hormone MRI = magnetic resonance imaging GICAA = giant internal carotid artery aneurysmhttp://www.sciencedirect.com/science/article/pii/S2376060520303023
collection DOAJ
language English
format Article
sources DOAJ
author Michael H. Goldman, MD
Alison T. Gruber
Marc A. Herman, MD
spellingShingle Michael H. Goldman, MD
Alison T. Gruber
Marc A. Herman, MD
Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
AACE Clinical Case Reports
author_facet Michael H. Goldman, MD
Alison T. Gruber
Marc A. Herman, MD
author_sort Michael H. Goldman, MD
title Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
title_short Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
title_full Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
title_fullStr Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
title_full_unstemmed Concurrent Panhypopituitarism and Hyperprolactinemia Due to a Giant Internal Carotid Aneurysm Revealed by Thyroid Hormone Withdrawal During Follow-Up Management of Thyroid Cancer
title_sort concurrent panhypopituitarism and hyperprolactinemia due to a giant internal carotid aneurysm revealed by thyroid hormone withdrawal during follow-up management of thyroid cancer
publisher Elsevier
series AACE Clinical Case Reports
issn 2376-0605
publishDate 2016-01-01
description ABSTRACT: Objective: This article reports a case of secondary hypothyroidism occurring during the withdrawal of thyroid hormone replacement in a patient with thyroid cancer that led to the discovery of simultaneous panhypopituitarism and hyperprolactinemia that were caused by an internal carotid artery aneurysm. The discovery of the secondary hypothyroidism necessitated further pituitary hormone analysis and medical imaging to identify the precise pathologic etiology.Methods: The methods used included the evaluation of selected thyroid and pituitary hormone concentrations and subsequent pituitary magnetic resonance imaging.Results: An 86-year-old African-American female with a history of thyroid cancer exhibited a suppressed serum thyroid-stimulating hormone concentration that failed to increase during progressive lowering of her thyroxine dosage despite it causing a simultaneous subnormal free thyroxine concentration. Laboratory findings indicated secondary hypothyroidism and subsequently panhypopituitarism and hyperprolactinemia. Pituitary magnetic resonance imaging revealed the presence of a large carotid aneurysm that had invaded the sella turcica. Additional hormone analyses revealed elevated prolactin, low gonadotropins, low baseline cortisol within an inappropriately normal adrenocorticotropic hormone concentration, and a low cortisol concentration following cortrosyn stimulation.Conclusion: Panhypopituitarism and hyperprolactinemia were revealed in a patient with thyroid cancer during thyroid hormone withdrawal, leading to the discovery of a giant internal carotid artery aneurysm invading the pituitary fossa. Physicians should be alert to the possibility of secondary hypopituitarism when an expected rise in thyroid-stimulating hormone while tapering thyroid hormone replacement in a low risk thyroid cancer patient fails to occur.Abbreviations: FT4 = free thyroxine TSH = thyroid stimulating hormone MRI = magnetic resonance imaging GICAA = giant internal carotid artery aneurysm
url http://www.sciencedirect.com/science/article/pii/S2376060520303023
work_keys_str_mv AT michaelhgoldmanmd concurrentpanhypopituitarismandhyperprolactinemiaduetoagiantinternalcarotidaneurysmrevealedbythyroidhormonewithdrawalduringfollowupmanagementofthyroidcancer
AT alisontgruber concurrentpanhypopituitarismandhyperprolactinemiaduetoagiantinternalcarotidaneurysmrevealedbythyroidhormonewithdrawalduringfollowupmanagementofthyroidcancer
AT marcahermanmd concurrentpanhypopituitarismandhyperprolactinemiaduetoagiantinternalcarotidaneurysmrevealedbythyroidhormonewithdrawalduringfollowupmanagementofthyroidcancer
_version_ 1721498500741464064